Desensitization of HLA-incompatible kidney recipients [3]

New England Journal of Medicine

Volumn 365, Issue 17, 2011, Pages 1644-

  Morath, Christian ^a   Zeier, Martin ^a   Süsal, Caner ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DESENSITIZATION; DIALYSIS; GRAFT RECIPIENT; HLA INCOMPATIBILITY; HLA MATCHING; HOSPITAL ADMISSION; HUMAN; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; LETTER; LIVING DONOR; PRIORITY JOURNAL; SURVIVAL RATE; CHRONIC KIDNEY FAILURE; FEMALE; IMMUNOLOGY; MALE; METHODOLOGY; NOTE; PLASMAPHERESIS;

IMMUNOGLOBULIN;

DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; PLASMAPHERESIS;

EID: 80054884865     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Vo AA, Lukovsky M, Toyoda M, et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 2008;359:242-51.
2. Bartel G, Wahrmann M, Regele H, et al. Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation. Am J Transplant 2010;10:2033-42.
3. Claas FH, Witvliet MD, Duquesnoy RJ, Persijn GG, Doxiadis II. The Acceptable Mismatch Program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome. Transplantation 2004;78:190-3.
4. Morath C, Beimler J, Opelz G, et al. An integrative approach for the transplantation of high-risk sensitized patients. Transplantation 2010;90:645-53.